Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: Rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE)

Diabetes, Obesity and Metabolism

Volumn 12, Issue 5, 2010, Pages 452-454

  Kashyap, Sangeeta R ^a   Bhatt, Deepak L ^a   Schauer, Philip R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Diabetes; Obesity; Weight loss

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; BARIATRIC SURGERY; CLINICAL TRIAL; GASTRECTOMY; HUMAN; LAPAROSCOPIC SURGERY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ROUX Y ANASTOMOSIS; STOMACH BYPASS; WEIGHT REDUCTION;

EID: 77952040914     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2009.01172.x     Document Type: Article

References (11)

1. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998, 22:39-47.
2. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003, 144:5159-5165.
3. Buchwald H, Avidor Y, Braunwald E. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292:1724-1737.
4. Sjostrom L, Lindroos AK, Peltonen M. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004, 351:2683-2693.
5. O'Brien PE, Dixon JB, Laurie C, Anderson M. A prospective randomized trial of placement of the laparoscopic adjustable gastric band: comparison of the perigastric and pars flaccida pathways. Obes Surg 2005, 15:820-826.
6. Schauer PR, Burguera B, Ikramuddin S. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003, 238:467-484.
7. Guidone C, Manco M, Valera-Mora E. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006, 55:2025-2031.
8. Laferrere B, Heshka S, Wang K. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007, 30:1709-1716.
9. le Roux CW, Aylwin SJ, Batterham RL. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006, 243:108-114.
10. Roa PE, Kaidar-Person O, Pinto D, Cho M, Szomstein S, Rosenthal RJ. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg 2006, 16:1323-1326.
11. Nathan DM, Buse JB, Davidson MB. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2008, 31:173-175.